# Combining Predictive Models of Mortality and Time-to-Discharge for Improved Outcome Assessment in Intensive Care Units

**Authors:** Àlex Pardo, Josep Gómez, Julen Berrueta, Alejandro García, Sara Manrique, Alejandro Rodríguez, María Bodí

PMC · DOI: 10.3390/jcm14134515 · Journal of Clinical Medicine · 2025-06-25

## TL;DR

This paper introduces a new model called PADS that predicts both mortality and discharge likelihood in ICU patients, helping doctors make better decisions and manage resources more effectively.

## Contribution

The novel contribution is a combined predictive model using LSTM networks to assess mortality and discharge likelihood in real-time for ICU patients.

## Key findings

- PADS achieved an AUCROC of 0.94 for mortality prediction and 0.89 for discharge prediction on training data.
- The model outperformed existing benchmarks like APS III, OASIS, and SAPS II by 7.4% to 19% in accuracy.
- The model's predictions are visualized in an intuitive format to aid clinical interpretation.

## Abstract

Background: The Patient Outcome Assessment and Decision Support (PADS) model is a real-time framework designed to predict both mortality and the likelihood of discharge within 48 h in critically ill patients. By combining these predictions, PADS enables clinically meaningful stratification of patient trajectories, supporting bedside decision-making and the planning of critical care resources such as nursing allocation and surgical scheduling. Methods: PADS integrates routinely collected clinical data: SOFA variables, age, gender, admission type, and comorbidities. It consists of two Long Short-Term Memory (LSTM) neural networks—one predicting the probability of death and the other the probability of discharge within 48 h. The combination places each patient into one of four states: alive/discharged within 48 h, alive/not discharged, dead within 48 h, or dead later. The model was trained using MIMIC-IV data, emphasizing ease of implementation in units with electronic health records. Out of the 76,540 stays present in MIMIC-IV (53,150 patients), 32,875 (25,555 patients) were used after excluding those with short stays (<48 h) or life support treatment limitations. The code is open, well-documented, and designed for reproducibility and external validation. Results: The model achieved strong performance: AUCROC of 0.94 (±0.03) for mortality and 0.89 (±0.07) for discharge on training data, and 0.87 (±0.02) and 0.88 (±0.03), respectively, on the test set. As a comparison, benchmark models obtain worse accuracy (−13.4% for APS III, −19% for OASIS, and −7.4% for SAPS II). Predictions are visualized in an intuitive format to support clinical interpretation. Conclusions: PADS offers a transparent, reproducible, and practical tool that supports both individual patient care and the strategic organization of intensive care resources by anticipating short-term outcomes.

## Full-text entities

- **Genes:** CREB3L1 (cAMP responsive element binding protein 3 like 1) [NCBI Gene 90993] {aka C16DELp11.2, DEL16p11.2, OASIS, OI16}
- **Diseases:** APS III (MESH:D016884), critically ill (MESH:D016638), SAPS II (MESH:C537730), death (MESH:D003643), dead (MESH:D001926)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12249738/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12249738/full.md

## References

36 references — full list in the complete paper: https://tomesphere.com/paper/PMC12249738/full.md

---
Source: https://tomesphere.com/paper/PMC12249738